Design and in vivo evaluation of a molecularly defined acellular skin construct: Reduction of early contraction and increase in early blood vessel formation
Source abstract
Abstract
Skin substitutes are of great benefit in the treatment of patients with full thickness wounds, but there is a need for improvement with respect to wound closure with minimal contraction, early vascularisation, and elastin formation. In this study we designed and developed an acellular double-layered skin construct, using matrix molecules and growth factors to target specific biological processes. The epidermal layer was prepared using type I collagen, heparin and fibroblast growth factor 7 (FGF7), while the porous dermal layer was prepared using type I collagen, solubilised elastin, dermatan sulfate, heparin, fibroblast growth factor 2 (FGF2) and vascular endothelial growth factor (VEGF). The construct was biochemically and morphologically characterised and evaluated in vivo using a rat full thickness wound model. The results were compared with the commercial skin substitute IntegraDRT and untreated wounds. The double-layered construct was prepared according to the design specifications. The epidermal layer was about 40 μm thick, containing 9% heparin and 0.2 μg FGF7 mg per layer, localised at the periphery. The dermal layer was 2.5 mm thick, had rounded pores and contained 10% dermatan sulfate+heparin, and 0.7 μg FGF2+VEGF mg per layer. The double-layered skin construct was implanted in a skin defect and on day 7, 14, 28 and 112 the (remaining) wound area was photographed, excised and (immuno) histologically evaluated. The double-layered skin construct showed more cell influx, significantly less contraction and increased blood vessel formation at early time points in comparison with IntegraDRT and/or the untreated wound. On day 14 the double-layered skin construct also had the fewest myofibroblasts present. On day 112 the double-layered skin construct contained more elastic fibres than IntegraDRT and the untreated wound. Structures resembling hair follicles and sebaceous glands were found in the double-layered skin construct and the untreated wound, but hardly any were found in IntegraDRT. The results provide new opportunities for the application of acellular skin constructs in the treatment of surgical wounds.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Wound Healing and Treatments · Dermatologic Treatments and Research · Fibroblast Growth Factor Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Simultaneous in vivo regeneration of neodermis, epidermis, and basement membrane
2. Progress and opportunities for tissue-engineered skin10.1038/nature05664 ↗
3. Tissue-engineered human living skin substitutes: development and clinical application10.3349/ymj.2000.41.6.774 ↗
4. Effect of collagen matrices on dermal wound healing10.1016/j.addr.2003.08.003 ↗
5. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers10.2165/00063030-200216060-00005 ↗
6. A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers10.2147/ciia.2007.2.1.93 ↗
7. Attachment of glycosaminoglycans to collagenous matrices modulates the tissue response in rats10.1016/S0142-9612(00)00052-1 ↗
8. Loading of collagen–heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats10.1002/jbm.10267 ↗
9. A biomaterial composed of collagen and solubilized elastin enhances angiogenesis and elastic fiber formation without calcification10.1089/tea.2007.0076 ↗
10. Tissue response of defined collagen–elastin scaffolds in young and adult rats with special attention to calcification10.1016/j.biomaterials.2004.02.011 ↗
11. Increased angiogenesis and blood vessel maturation in acellular collagen–heparin scaffolds containing both FGF2 and VEGF10.1016/j.biomaterials.2006.10.029 ↗
12. Biological molecule-impregnated polyester: an in vivo angiogenesis study10.1016/0142-9612(96)87645-9 ↗
13. FGF-2-loaded collagen scaffolds attract cells and blood vessels in rat oral mucosa10.1111/j.1600-0714.2009.00763.x ↗
14. The effect of myofibroblast on contracture of hypertrophic scar10.1097/01.PRS.0000101530.33096.5B ↗
15. TGF-beta and bFGF affect the differentiation of proliferating porcine fibroblasts into myofibroblasts in vitro10.1016/S0142-9612(99)00077-0 ↗
16. Heparin stimulates production of bFGF and TGF-beta 1 by human normal, keloid, and fetal dermal fibroblasts
17. A molecularly defined array based on native fibrillar collagen for the assessment of skin tissue engineering biomaterials10.1016/j.biomaterials.2009.07.050 ↗
18. Reduced contraction of skin equivalent engineered using cell sheets cultured in 3D matrices10.1016/j.biomaterials.2006.04.020 ↗
19. Novel application method of artificial dermis: one-step grafting procedure of artificial dermis and skin, rat experimental study10.1016/j.burns.2005.10.013 ↗
20. Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate10.1016/S0142-9612(98)00240-3 ↗
21. Cloning, large-scale production, and purification of active dimeric rat vascular endothelial growth factor (rrVEGF-164)10.1016/j.pep.2009.08.015 ↗
22. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology
23. Dermatan sulfate domains defined by the novel antibody GD3A12, in normal tissues and ovarian adenocarcinomas10.1007/s00418-009-0592-2 ↗
24. Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis10.1111/j.0022-202X.2004.22316.x ↗
25. Development of tailor-made collagen–glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects10.1016/S0142-9612(99)00222-7 ↗
26. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide10.1016/0142-9612(96)81413-X ↗
27. “Western blotting”: electrophoretic transfer of proteins from sodium dodecyl sulfate–polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A10.1016/0003-2697(81)90281-5 ↗
28. Bancroft · 1990
29. A combination Verhoeff’s elastic and Masson’s trichrome stain for routine histology10.3109/10520298209066710 ↗
30. Design of an artificial skin. II. Control of chemical composition10.1002/jbm.820140203 ↗
31. The effect of basic fibroblast growth factor on scarring10.1054/bjps.2002.3831 ↗
32. A new dermal equivalent: the use of dermal fibroblast culture alone without exogenous materials10.1016/j.jdermsci.2006.03.007 ↗
33. Effects of fibroblasts and microenvironment on epidermal regeneration and tissue function in long-term skin equivalents10.1016/j.ejcb.2006.12.005 ↗
34. Similarities and differences between induced organ regeneration in adults and early foetal regeneration10.1098/rsif.2005.0062 ↗
35. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol 2001;2:Reviews3005.10.1186/gb-2001-2-3-reviews3005 ↗
36. Spatial and temporal expression of basic fibroblast growth factor protein during wound healing of rat skin10.1046/j.1365-2133.2000.03824.x ↗
37. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix10.1002/jemt.10249 ↗
38. Angiogenesis with biomaterial-based drug- and cell-delivery systems10.1163/156856204774196117 ↗
39. Reconstructive surgery with Integra dermal regeneration template: histologic study, clinical evaluation, and current practice10.1097/01.prs.0000222609.40461.68 ↗
40. Pathologic scar formation. Morphologic and biochemical correlates
41. Construction of collagen scaffolds that mimic the three-dimensional architecture of specific tissues10.1089/ten.2006.0320 ↗
42. Cell orientation determines the alignment of cell-produced collagenous matrix10.1016/S0021-9290(02)00233-6 ↗
43. Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding10.1038/nature05766 ↗
44. Hair growth induction: roles of growth factors10.1111/j.1749-6632.1991.tb24397.x ↗